This poster demonstrates potential of genetically modified plants in vaccine development, highlighting innovative examples like Medicago's CoVLP.
Plant-based vaccines use genetically modified plants to produce immunogenic proteins capable of triggering protective immune responses in humans and animals. This poster summarizes current methodologies, evidence from systems such as Nicotiana benthamiana, and examples including Medicago’s CoVLP and the Ebola-targeting ZMapp. It highlights advantages, challenges, and future prospects of plant-derived vaccine platforms.
No takes yet. Share an insight, caveat, or question.
Singh Astha (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: